Blogvesting

I liquidated ZINC today at $6.99, less than a week after I bought it for $7.90, for an excruciating 12% loss. I bought this position because of its compelling valuation, despite deteriorating technical indicators. This is what I deserve for disregarding the old adage about not catching a falling knife. Still, I had to follow [...]

[Read more →]

I liquidated WMT today at $59.08, for a gain of 25%. When I bought this position about a year ago, I felt that its overseas operations, which make up more than 20% of revenue now, was being under-valued, and that a potential recession could boost its domestic market share. Also, Joel Greenblatt’s huge position in [...]

[Read more →]

I took advantage of the market upswing today to liquidate a few positions that I feel are near their fair value. First up on the chopping block is Methanex, which supplies 20% of the world’s methanol, used mainly in the chemical industry. I first bought MEOH on August 2007, and my investment thesis was that [...]

[Read more →]

Dow Chemical requires no introduction. Buffett financed Dow’s acquisition of Rohm and Haas with a convertible bond yielding 8.5% and convertible at a share price of $41. There is some debate about whether Dow overpaid for its new acquisition, but the consensus is that the company has a better product mix and market share after [...]

[Read more →]

Having just written up a couple of my most recent stock purchases, I am suddenly struck by how naive some of my bullish commentary sounds. In every investment thesis, there is some risk, and it is always possible to find reasons why a stock can tank. In the current pessimistic climate, writing a negative article [...]

[Read more →]